Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT – Get Free Report) was the target of a significant drop in short interest during the month of October. As of October 15th, there was short interest totaling 67,594 shares, a drop of 41.3% from the September 30th total of 115,090 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average daily volume of 3,118,131 shares, the short-interest ratio is currently 0.0 days.
Zhengye Biotechnology Trading Up 2.3%
NASDAQ ZYBT opened at $1.33 on Tuesday. The business’s fifty day moving average is $1.46 and its 200 day moving average is $1.16. Zhengye Biotechnology has a fifty-two week low of $0.62 and a fifty-two week high of $8.01.
Analyst Ratings Changes
Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Zhengye Biotechnology in a research note on Friday, October 16th. One analyst has rated the stock with a Sell rating. According to MarketBeat.com, Zhengye Biotechnology presently has a consensus rating of “Sell”.
Check Out Our Latest Report on Zhengye Biotechnology
About Zhengye Biotechnology
Zhengye Biotechnology Group Co, Ltd. is a China-based biotechnology company focused on developing, manufacturing and selling biological products for the agricultural and animal husbandry industries. Its business is centered on applying microbial technologies to support animal health, livestock production and crop cultivation.
The company’s product offerings include microbial-based products used in animal feed and agricultural production, as well as related biological solutions intended to improve farming efficiency and promote healthier livestock and crops.
See Also
- Five stocks we like better than Zhengye Biotechnology
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Zhengye Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhengye Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
